卷 23, 编号 1 (2021) |
CLINICAL ONCOLOGY |
Comparison of the efficacy of first-line therapy with different generations of EGFR tyrosine kinase inhibitors in patients with advanced EGFR-associated non-small cell lung cancer: a network meta-analysis of overall survival data |
(Rus)
|